CareDx’s KidneyCare iBox Technology Clinically Validated in BMJ Publication
“Our BMJ publication shows the algorithm we created can provide standardization across centers worldwide,” said
The BMJ study’s aim was to validate the iBox integrative system to predict long-term allograft failure. The study assessed the performance of the iBox risk prediction score in 7,557 kidney transplant recipients with a median follow-up time of 7 years, across 10 academic medical centers from
“Transplantation provides an incredibly rich data set and is ripe for using augmented intelligence tools to better assess risk and help physicians better manage their daily patient care. Our next step is clinical utility, which we capture through our OKRA registry measuring outcomes from patients surveilled with KidneyCare,” said Sham Dholakia, MD, DPhil, CareDx’s Senior Vice President of Medical Affairs & Clinical Operations.
For more information, please visit: www.CareDx.com.
Forward Looking Statements
This press release includes forward-looking statements, including statements regarding iBox. These forward-looking statements are based upon information that is currently available to
Chief Marketing Officer,
Chief Financial Officer,
Source: CareDx, Inc.